125 related articles for article (PubMed ID: 10802157)
1. Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients.
Suzuki K; Sugimoto C; Takizawa M; Ishizuka S; Kikuyama M; Togawa H; Taguchi Y; Nosaka K; Seino Y; Ishida H
Diabetes Res Clin Pract; 2000 Jun; 48(3):185-91. PubMed ID: 10802157
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral metabolism is normal in non-insulin-dependent diabetes mellitus.
Sosa M; Dominguez M; Navarro MC; Segarra MC; Hernández D; de Pablos P; Betancor P
J Diabetes Complications; 1996; 10(4):201-5. PubMed ID: 8835919
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
Jehle PM; Jehle DR; Mohan S; Böhm BO
J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
[TBL] [Abstract][Full Text] [Related]
4. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
5. Possible compensatory role of parathyroid hormone-related peptide on maintenance of calcium homeostasis in patients with non-insulin-dependent diabetes mellitus.
Ishida H; Suzuki K; Someya Y; Nishimura M; Sugimoto C; Goto M; Taguchi Y; Kasahara H; Kadowaki S; Imura H
Acta Endocrinol (Copenh); 1993 Dec; 129(6):519-24. PubMed ID: 8109185
[TBL] [Abstract][Full Text] [Related]
6. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
8. Lumbar spine bone mineral density in diabetic children with recent onset.
De Schepper J; Smitz J; Rosseneu S; Bollen P; Louis O
Horm Res; 1998; 50(4):193-6. PubMed ID: 9838239
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.
Muñoz-Torres M; Jódar E; Escobar-Jiménez F; López-Ibarra PJ; Luna JD
Calcif Tissue Int; 1996 May; 58(5):316-9. PubMed ID: 8661964
[TBL] [Abstract][Full Text] [Related]
10. Bone metabolism, density, and geometry in postmenopausal women with vitamin D insufficiency: a cross-sectional comparison of the effects of elevated parathyroid levels.
Rødbro LL; Bislev LS; Sikjær T; Rejnmark L
Osteoporos Int; 2018 Oct; 29(10):2211-2218. PubMed ID: 29955908
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
Fidan N; Inci A; Coban M; Ulman C; Kursat S
J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density in primary care patients related to serum calcium concentrations: a longitudinal cohort study from Sweden.
Dalemo S; Eggertsen R; Hjerpe P; Almqvist EG; Boström KB
Scand J Prim Health Care; 2018 Jun; 36(2):198-206. PubMed ID: 29623754
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D status and parathyroid hormone levels in relation to bone mineral density in apparently healthy Syrian adults.
Sayed-Hassan R; Abazid N; Koudsi A; Alourfi Z
Arch Osteoporos; 2016; 11():18. PubMed ID: 27126333
[TBL] [Abstract][Full Text] [Related]
14. Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes?
Gregorio F; Cristallini S; Santeusanio F; Filipponi P; Fumelli P
Diabetes Res Clin Pract; 1994 Feb; 23(1):43-54. PubMed ID: 8013262
[TBL] [Abstract][Full Text] [Related]
15. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism.
Dobnig H; Kainer F; Stepan V; Winter R; Lipp R; Schaffer M; Kahr A; Nocnik S; Patterer G; Leb G
J Clin Endocrinol Metab; 1995 Dec; 80(12):3699-707. PubMed ID: 8530622
[TBL] [Abstract][Full Text] [Related]
16. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
17. Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus.
Nagasaka S; Murakami T; Uchikawa T; Ishikawa SE; Saito T
Endocr J; 1995 Jun; 42(3):377-83. PubMed ID: 7670567
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene, biochemical bone markers and bone mineral density in Mexican women on dialysis.
Avila M; Prado C; Ventura MD; Mora C; Briones D; Valdez H; Hurtado ME; Lindholm B; Qureshi A; Castillo-Henkel C; Paniagua R
Nephrol Dial Transplant; 2010 Jul; 25(7):2259-65. PubMed ID: 20124547
[TBL] [Abstract][Full Text] [Related]
19. Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.
Terzi R; Dindar S; Terzi H; Demirtaş Ö
Metab Syndr Relat Disord; 2015 Mar; 13(2):78-83. PubMed ID: 25470355
[TBL] [Abstract][Full Text] [Related]
20. Bone metabolism in endurance trained athletes: a comparison to population-based controls based on DXA, SXA, quantitative ultrasound, and biochemical markers.
Brahm H; Ström H; Piehl-Aulin K; Mallmin H; Ljunghall S
Calcif Tissue Int; 1997 Dec; 61(6):448-54. PubMed ID: 9383270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
